7301 Mission Rd Suite 234 Building A, Prairie Village, KS
Botox · 150 reviews
By Sarah, Aesthetics Editor, Medical Spa Locator · Reviewed by Anna M. Melamed, MD · Data last checked
3 listed tirzepatide (mounjaro/zepbound) providers across Kansas. Sponsored placements appear first; other listings follow by Google rating. Pricing typically runs $400–$1,500 per month per session — request quotes and confirm credentials directly. Ratings and review counts are sourced from Google Places. Snapshot generated September 2026.
Directory snapshot generated
7301 Mission Rd Suite 234 Building A, Prairie Village, KS
Botox · 150 reviews
3800 W 75th St studio 3, Prairie Village, KS
Laser Treatments · 27 reviews
Tirzepatide is a dual GIP/GLP-1 receptor agonist that provides significant weight loss by targeting two gut hormones.
Typical Cost
$400–$1,500 per month
Duration
Weekly injection
Providers in Kansas
3
Medical Spa Locator lists 3 tirzepatide (mounjaro/zepbound) providers across Kansas. Use the listings above to compare Google rating and review count, then independently confirm practitioner credentials and treatment availability.
Tirzepatide (Mounjaro/Zepbound) in Kansas typically costs $400–$1,500 per month. Prices vary by city, provider experience, and treatment area. Request quotes from multiple clinics and ask about new patient specials.
Look for a Kansas tirzepatide (mounjaro/zepbound) provider with a licensed medical director, certified injectors or technicians, verified Google reviews, and transparent pricing. Complimentary consultations are common — take advantage of them before committing.
Kansas requires medical spas to operate under physician oversight. When performed by a licensed and experienced provider, tirzepatide (mounjaro/zepbound) is considered safe. Always verify your provider's credentials and ask about their training before your appointment.
The best city in Kansas for tirzepatide (mounjaro/zepbound) depends on your location and preferences. Larger metro areas generally offer more provider options and competitive pricing. Browse the listings above — they are sorted by Google rating, so the highest-rated clinics appear first.
Tirzepatide targets two receptors (GIP and GLP-1) compared to one for semaglutide, often resulting in greater weight loss.
In the FDA label's 72-week Zepbound study of adults without diabetes, mean body-weight change ranged from -15.0% at 5 mg to -20.9% at 15 mg, versus -3.1% with placebo; all groups received diet and activity intervention. Individual outcomes vary.
Claim your free listing to appear on this page and start receiving exclusive leads.
Claim Your Listing